SEARCH:   Advanced

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Ogata, N. Articles by Takatsu, K. Search for Related Content PubMed PubMed Citation Articles by Ogata, N. Articles by Takatsu, K. Related Collections Hematopoiesis and Stem Cells Social Bookmarking                   What's this?  Previous Article  |  Table of Contents  |  Next Article  Blood, Vol. 91 No. 7 (April 1), 1998: pp. 2264-2271 JAK2 and JAK1 Constitutively Associate With an Interleukin-5 (IL-5) Receptor  and c Subunit, Respectively, and Are Activated Upon IL-5 Stimulation By Norihisa Ogata, Taku Kouro, Atsuko Yamada, Masamichi Koike, Nobuo Hanai, Takeru Ishikawa, and Kiyoshi Takatsu From the Department of Immunology, Institute of Medical Science, University of Tokyo, Tokyo; Tokyo Research Institute, Kyowa-Hakko Kogyo Co, Tokyo; and Department of Otorhinolaryngology, Kumamoto University School of Medicine, Kumamoto, Japan.     ABSTRACT Abstract Introduction Methods Results Discussion References The human interleukin-5 receptor (hIL-5R) consists of a unique  subunit (hIL-5R) and a common  subunit (c) that activate two Janus kinases (JAK1 and JAK2) and a signal transducer and activator of transcription (STAT5). The precise stoichiometry of the hIL-5R subunits and the role of JAK kinases used in IL-5 signaling were investigated. We analyzed the interaction between hIL-5R and c by immunoprecipitation using anti-hIL-5R and anti-c monoclonal antibodies. The binding of JAK1 and JAK2 to each hIL-5R subunit was also evaluated in the hIL-5-responsive cell line, TF-h5R. It was observed that IL-5 stimulation induced the recruitment of c to hIL-5R, although in the absence of IL-5 the subunits remain independent. In the absence of IL-5, JAK2 and JAK1 were associated with hIL-5R and c, respectively. IL-5 stimulation resulted in tyrosine phosphorylation of JAK2, JAK1, c, and STAT5. Moreover, IL-5-induced dimerization of IL-5R subunits caused JAK2 activation and c phosphorylation even in the absence of JAK1 activation. Furthermore, tyrosine phosphorylation of JAK1 was dependent on the activation of JAK2. Detailed study of the C-terminal truncated cytoplasmic domain of hIL-5R revealed that the cytoplasmic stretch at position 346-387, containing the proline-rich region, is necessary for JAK2 binding. These observations suggest that activation of hIL-5R-associated JAK2 is indispensable for the IL-5 signaling event.     INTRODUCTION Abstract Introduction Methods Results Discussion References HUMAN INTERLEUKIN-5 (hIL-5) is a cytokine responsible for the proliferation, differentiation, and activation of eosinophils.1-3 Accumulating evidence suggests that eosinophils recruited by hIL-5 play a crucial role in allergic diseases such as bronchial asthma and in parasitic infections.3 hIL-5 induces intracellular signals after binding to the functional hIL-5 receptor (hIL-5R) complex consisting of the hIL-5R and  subunits.4-6 Binding of hIL-5 occurs specifically through hIL-5R, which alone binds hIL-5 (kd, 250 to 590 pmol/L).5 Although the  subunit does not bind hIL-5 by itself, it does form a high-affinity receptor in combination with hIL-5R.5-7 The  subunit is the common  subunit (c) of receptors for IL-3 and granulocyte-macrophage colony-stimulating factor (GM-CSF).6-9 Recent studies of the IL-3R and GM-CSFR have shown that each ligand triggers heterodimerization of the ligand-specific  and c subunits.10-12 However, the formation of functional hIL-5R complexes has not yet been elucidated clearly. Tyrosine phosphorylation of several cellular proteins, including c, occurs within a few minutes in response to IL-5 stimulation.13,14 Because hIL-5R and c do not contain a kinase domain or kinase activity in their structures, signaling via IL-5R must originate in activation of cytoplasmic kinases that are associated with hIL-5R subunits. The Janus kinases ([JAKs] JAK1, JAK2, JAK3, and TYK2),15-17 a family of nonreceptor tyrosine kinases, are likely candidates for regulating IL-5 signaling.18,19 Indeed, IL-5 was found to activate JAK1 and JAK2, resulting in the activation of downstream signal transducers and activators of transcription (STAT5, STAT1, and STAT3).20-24 The cytoplasmic domain of c, particularly the membrane-proximal region containing the box1 motif, has been shown to regulate JAK2 activation in the GM-CSFR system.25 We have previously reported the indispensable role of the cytoplasmic domain of mouse IL-5R for IL-5-induced activation of JAK1 and JAK2.13,24 The precise stoichiometry of the molecular interactions between JAKs (JAK1 and JAK2) and each hIL-5R subunit in IL-5-mediated signal transduction remained to be elucidated. To reevaluate the role of the hIL-5R cytoplasmic domain in regulating JAK activation, the associations of JAK1 and JAK2 with hIL-5R and c were examined. We describe the unassociated state of hIL-5R and c subunits in the absence of IL-5. Following hIL-5 stimulation, hIL-5R subunits with their respective associated JAK2 and JAK1 are phosphorylated on their tyrosine residues and heterodimerized. Furthermore, we describe the activation of JAK2 in the absence of JAK1 activation.     MATERIALS AND METHODS Abstract Introduction Methods Results Discussion References Reagents.   Baculovirus-expressed recombinant hIL-5 was purified to homogeneity from the supernatant of SF9 cells using single-step immunoaffinity chromatography with an anti-IL-5 monoclonal antibody (MoAb) as previously described.7 Mono5 (biologically active monomeric IL-5) was prepared as previously described.26 Human GM-CSF was kindly provided by Kirin Brewery Co (Maebashi, Japan). The MoAbs against hIL-5R (KM1266 and KM1074) have been established27 and were purified using Protein G-coupled Sepharose (Pharmacia Biotech, Uppsala, Sweden) from ascites of nude mice transplanted with a hybridoma. Rabbit anti-STAT5 antiserum was kindly provided by H. Wakao (DNAX Research Institute, Palo Alto, CA). MoAbs and polyclonal antibodies (Abs) against c were obtained from Santa Cruz Biotechnology Inc (Santa Cruz, CA). Antiphosphotyrosine Ab 4G10 and antiserum against JAK1 and JAK2 were obtained from Upstate Biotechnology Inc (Lake Placid, NY). Cells.   TF-1 cells,28 a human proerythroleukemic cell line, were kindly provided by T. Kitamura (DNAX Research Institute). TF-h5R cells,22 TF-1 cells transfected with hIL-5R cDNA, were maintained in RPMI 1640 supplemented with 10% fetal calf serum (FCS) containing 5 ng/mL hIL-5. YY-1 cells, an eosinophilic subline of HL-60, were maintained in Iscove's modified Dulbecco's medium supplemented with 10% FCS. To induce expression of hIL-5R, YY-1 cells were incubated at 2 × 105 cells/mL with 0.4 mmol/L sodium butyrate (pH 7.8) for 1 week before use, as previously described (YY-Bu).22 Constructs of glutathione S-transferase fusion proteins and kinase-negative JAKs.   cDNA constructs encoding the glutathione S-transferase (GST) fusion protein for the entire hIL-5R cytoplasmic domain were obtained by inserting the polymerase chain reaction (PCR) fragments of hIL-5R into the EcoRI/Xho I site of the pGEX4T-1 vector (Pharmacia Biotech). The following fusion protein constructs (with corresponding amino acids indicated) were also generated by PCR for this study: GST-5RCD (346-400), GST-TCD4 (346-387), GST-TCD2 (346-365), GST-TCD1-1 (346-358), GST-TCD1 (346-356), GST-TCD0 (346-351), and GST-dDC1 (346-350/359-400). cDNA encoding GST fusion protein with the cytoplasmic domain of the c subunit was constructed by ligating the fragment, which was digested by FspI/BglII and followed by a fill-in reaction, into pGEX4T-3 vector (Pharmacia Biotech). The c fragment corresponds to amino acid 456 to 544 of the c (GST-BCD). These GST fusion proteins were expressed in Escherichia coli, and were affinity-purified on glutathione-Sepharose (Pharmacia Biotech). JAK1 cDNA (pBSK-JAK1) was kindly provided by J. Ihle (St Jude Childrens Research Hospital, Memphis, TN). The kinase-negative JAK1 that lacks the C-terminus kinase domain was isolated from the Sal I and BglII sites. A Not I linker was attached the BglII site of the fragment and inserted into the Xho I and Not I sites of pME18S. The expression plasmid for a kinase-negative JAK2 (pME18S JAK2)25 was a kind gift from S. Watanabe (Institute of Medical Science, University of Tokyo, Tokyo, Japan). Immunoprecipitation and immunoblotting.   Cells were stimulated with 300 ng/mL hIL-5 or GM-CSF for 3 minutes; following stimulation, they were lysed on ice in lysis buffer (1% Brij 97 or 1% Triton X-100, 10% glycerol, 150 mmol/L NaF, 1 mmol/L sodium orthovanadate, 100 U/mL aprotinin, 10 mmol/L iodoacetamide, and 25 µg/mL p-nitrophenyl-p-guanidinobenzoate). For immunoprecipitation, cell lysates (equivalent to 1 × 107 cells) were precleared with Protein G-Sepharose for 2 hours at 4°C and further incubated with various Abs for another 2 hours at 4°C. The immune complexes were precipitated by adding Protein G-Sepharose (Pharmacia Biotech), except in the case of the anti-hIL-5R MoAb KM1266, which was covalently bound to Sepharose beads (Pharmacia Biotech) before use. The immune complexes were washed with lysis buffer and subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis ([SDS-PAGE] 7.5% acrylamide gel). The proteins were transferred to Immobilon membranes (Millipore, Bedford, MA), and after blocking with Tris-buffered saline containing 5% bovine serum albumin (Fraction V; Sigma, St Louis, MO), the membranes were probed with anti-JAK2, anti-JAK1, anti-hIL-5R, anti-c, or antiphosphotyrosine Ab (4G10) and visualized by the ECL system (Amersham, Buckinghamshire, UK). Binding assay for GST fusion proteins with JAK.   The interaction of GST fusion proteins to JAK2 was examined as follows. Equal amounts of GST fusion proteins were incubated with lysates of unstimulated or hIL-5-stimulated TF-h5R cells, which were lysed with 0.5% Triton X-100 containing protease inhibitors, for 4 hours at 4°C and washed (0.1% Triton X-100). After adding sample buffer, the precipitates bound to GST fusion proteins were eluted by boiling and examined by immunoblotting with the Ab against JAK2 or JAK1. Expression of hIL-5R subunits, kinase-negative JAK1, and kinase-negative JAK2.   The expression plasmids for hIL-5R (5 µg) and c (5 µg) with or without kinase-negative JAK1 (15 µg) or kinase-negative JAK2 (15 µg) were transiently transfected into COS7 cells. COS7 cells were suspended in 800 µL cytomix29 (120 mmol/L KCl, 0.15 mmol/L CaCl2, 10 mmol/L K2HPO4/KH2PO4, 25 mmol/L HEPES, 2 mmol/L EGTA, and 5 mmol/L MgCl2, pH 7.6) and mixed with each plasmid. Electroporation was performed using a Gene Pulser (Bio-Rad, Hercules, CA) set at 960 µF and 300 V. After incubation for 36 hours, each group of cells was recovered for analysis.     RESULTS Abstract Introduction Methods Results Discussion References IL-5-induced interaction between hIL-5R and c.   We established two different hIL-5-responsive cell lines, TF-h5R and YY-Bu. As we previously reported,22 both TF-h5R and YY-Bu respond to hIL-5 and mono5 by proliferation and adhesion to fibronectin, respectively, in a dose-dependent manner to an extent similar to that obtained with GM-CSF stimulation. We also generated an MoAb against hIL-5R that could immunoprecipitate hIL-5R in the presence of hIL-5. The anti-hIL-5R MoAb KM1266 was able to coimmunoprecipitate c together with hIL-5R when lysates were obtained from hIL-5- and mono5-stimulated TF-h5R cells, but not with GM-CSF (Fig 1A). Essentially identical results were obtained using anti-c MoAb. The anti-c MoAb was able to coimmunoprecipitate hIL-5R together with c only when the cells were stimulated with IL-5 (Fig 1A). Sequential immunoblot analysis showed that the c coimmunoprecipitated with hIL-5R by anti-hIL-5R MoAb was tyrosine-phosphorylated. In contrast, the c immunoprecipitated from unstimulated TF-h5R cells by anti-c MoAb was not tyrosine-phosphorylated. Tyrosine phosphorylation of c was also observed in extracts of GM-CSF-stimulated TF-h5R cells; however, it was not associated with hIL-5R (Fig 1A). These observations indicate that a functional hIL-5R/c complex could be formed only in response to IL-5 stimulation. View larger version (24K): [in this window] [in a new window]   Fig 1. A functional hIL-5R complex is formed only after IL-5 stimulation, followed by JAK2 and JAK1 activation. (A) Unstimulated, IL-5-stimulated, mono5-stimulated, or GM-CSF-stimulated TF-h5R cells were lysed and immunoprecipitated with KM1266 (anti-hIL-5R MoAb) or anti-c MoAb. The immunoprecipitated proteins were analyzed on SDS-PAGE and transferred to Immobilon membranes. The membranes were probed with anti-c polyclonal Ab or KM1074 (anti-hIL-5R MoAb), respectively. The same membranes were reprobed with anti-hIL-5R or KM1074. Another immunoprecipitation analysis was made by immunoblotting with antiphosphotyrosine MoAb. (B) Unstimulated, IL-5-stimulated, or GM-CSF-stimulated TF-h5R cells were lysed, and immunoprecipitation was performed with anti-JAK1 or -JAK2 Ab. The immunoprecipitates were analyzed on SDS-PAGE and transferred to Immobilon membranes. The membranes were probed with antiphosphotyrosine MoAb 4G10 and reprobed with anti-JAK2 or -JAK1 Ab. IL-5-induced activation of JAKs and STATs.   We have reported that IL-5 induces tyrosine phosphorylation of JAK2, and to a lesser extent JAK1, in a murine B-cell line.24 To examine the involvement of JAK1 and JAK2 in the signal transduction of hIL-5, cell lysates of TF-h5R were immunoprecipitated with anti-JAK1 and anti-JAK2 antiserum. Each precipitate was then subjected to immunoblot analysis with antiphosphotyrosine MoAb. JAK2 was tyrosine-phosphorylated upon hIL-5 and GM-CSF stimulation. Moreover, a certain degree of JAK1 tyrosine phosphorylation was also observed. In both cases, tyrosine phosphorylation was observed within 2 minutes of hIL-5 stimulation. The same results were obtained when cell lysates of hIL-5- or GM-CSF-stimulated YY-Bu were used (Fig 1B). As we have previously demonstrated,22 STAT5 was found to be activated upon hIL-5 stimulation in both TF-h5R and YY-Bu. It has also been shown by our group and others20-22 that in human eosinophils STAT1 and STAT5 are activated after hIL-5 stimulation. We infer from these results that not only JAK2 but also JAK1 are tyrosine-phosphorylated in TF-h5R and YY-Bu cells in response to hIL-5 followed by STAT5 activation. Association of JAK2 and JAK1 with hIL-5R and c, respectively.   Although IL-5 induces tyrosine phosphorylation of cellular proteins including c, JAK1, JAK2, and STAT5, both IL-5R and c subunits do not contain an intrinsic kinase domain, suggesting the association of cellular tyrosine kinases. We evaluated the physical association of JAK1 and JAK2 with each component of the hIL-5R complex. Cellular extracts of TF-h5R were immunoprecipitated with anti-hIL-5R MoAb KM1266 followed by immunoblotting with anti-JAK2 or anti-JAK1 Ab. JAK2 was coimmunoprecipitated with hIL-5R regardless of IL-5 stimulation. Human IL-5 stimulation did not induce a significant increase of JAK2 protein coimmunoprecipitation with hIL-5R. On the other hand, JAK1 was coimmunoprecipitated with hIL-5R only when the cells were stimulated with hIL-5. In the absence of hIL-5 stimulation, no coimmunoprecipitation of JAK1 by anti-hIL-5R MoAb was observed (Fig 2A). View larger version (21K): [in this window] [in a new window]   Fig 2. JAK2 and JAK1 constitutively associate with hIL-5R and c, respectively. (A) Unstimulated or IL-5-stimulated TF-h5R cells were lysed and immunoprecipitated with anti-hIL-5R, KM1266, or control Ab. The immunoprecipitated proteins were analyzed on SDS-PAGE and transferred to Immobilon membranes. The membranes were probed with anti-JAK2 or anti-JAK1 Ab and reprobed with anti-hIL-5R MoAb KM1074. (B) Cell lysates from unstimulated or IL-5-stimulated TF-h5R cells were immunoprecipitated with anti-c MoAb or control Ab and separated on SDS-PAGE. The membrane was probed with anti-JAK1 Ab and reprobed with anti-c polyclonal Ab. Next, immunoprecipitation of cellular extracts from TF-h5R cells with anti-c MoAb followed by immunoblotting with anti-JAK1 Ab was performed. It was found that JAK1 coimmunoprecipitated with c regardless of hIL-5 stimulation (Fig 2B). Taken together, we infer from these results that JAK2 and JAK1 are constitutively associated with hIL-5R and c, respectively. To further determine the role of the cytoplasmic domain of hIL-5R in JAK2 association, we generated several GST fusion proteins containing the entire cytoplasmic domain (GST-5RCD), a deletion mutant of the proline-rich residues of the cytoplasmic domain (GST-dDC1), and several C-terminal truncated cytoplasmic domain mutants of hIL-5R (GST-TCD0 to GST-TCD4). Also, a GST fusion protein corresponding to the cytoplasmic region of c (GST-BCD) was prepared (Fig 3A and B). The molecular weight of each fusion protein was determined by SDS-PAGE analysis, and each was found to have the expected molecular weight (Fig 4B). Using these GST fusion proteins, we performed binding assays for the association of JAK2 to GST fusion proteins. When unstimulated or hIL-5-stimulated cell lysates of TF-h5R were incubated with GST alone, no JAK2 protein was detected by immunoblotting. GST fusion proteins containing the entire cytoplasmic domain of hIL-5R (GST-5RCD) bound JAK2 regardless of hIL-5 stimulation (Fig 4A). However, the GST fusion protein with the cytoplasmic region of the c (GST-BCD), which contained the box1 and box2 motifs, was unable to bind JAK2 (Fig 4A), confirming the result that JAK2 does not associate with c (Fig 2A). Furthermore, the GST fusion protein GST-dDC1, which has an eight-amino acid deletion mutation in the proline-rich region (DC1 region)13 of the cytoplasmic domain of hIL-5R, was unable to bind JAK2 (Fig 4B). This finding is in agreement with our previous observation, which confirms the role of this region in the activation of JAK2 in response to hIL-5. View larger version (26K): [in this window] [in a new window]   Fig 3. Schematic diagram showing various cytoplasmic hIL-5R fusion proteins (A) and the cytoplasmic c fusion protein (B). TM, transmembrane region. View larger version (24K): [in this window] [in a new window]   Fig 4. In vitro binding of the hIL-5R cytoplasmic domain to JAK2. (A) GST alone, hIL-5R cytoplasmic domain fusion protein (GST-5RCD), or c cytoplasmic domain fusion protein (GST-BCD) were incubated with the cell lysates of unstimulated () or IL-5-stimulated TF-h5R cells, and the precipitated proteins were analyzed on SDS-PAGE and probed with anti-JAK2 Ab. (B) The deletion mutant (dDC1) and C-terminal truncated (TCD4, TCD2, TCD1-1, TCD1, and TCD0) GST fusion proteins were incubated with the lysates of unstimulated TF-h5R, separated on SDS-PAGE, and probed with anti-JAK2 Ab. The same amount of fusion proteins were separated on SDS-PAGE and stained with Coomassie brilliant blue (CBB). Next, we examined whether the DC1 region containing the proline-rich residues, similar to the box1 region, of the cytoplasmic domain of hIL-5R alone was sufficient to associate with JAK2. For this purpose, we used a panel of fusion proteins corresponding to the C-terminal cytoplasmic truncated region of hIL-5R. GST-TCD4 was able to bind JAK2 significantly, but neither GST-TCD2, -TCD1-1, -TCD1, nor TCD0 bound to JAK2 (Fig 4B). These results indicate that the downstream region of the proline-rich motif is also indispensable for JAK2 binding to hIL-5. Dominant-negative JAK2 represses tyrosine phosphorylation of endogenous JAK2 and JAK1.   To further evaluate the role of JAK1 and JAK2 in IL-5 signaling, we introduced kinase-negative forms of JAK1 or JAK2 together with expression constructs of hIL-5R and c into COS7 cells. The COS7 transfectants expressing both hIL-5R and c responded to hIL-5 for tyrosine phosphorylation of endogenous JAK2 and JAK1. Overexpression of a kinase-negative form of JAK2 inhibited hIL-5-induced activation of endogenous JAK2, in agreement with a previous report.25 Overexpression of a kinase-negative form of JAK1 could also suppress hIL-5-induced activation of endogenous JAK1 (Fig 5A). These observations indicate that kinase-negative forms of both JAK1 and JAK2 function as dominant-negative JAK1 (DN-JAK1) and JAK2 (DN-JAK2), respectively, in hIL-5 signaling. Interestingly, overexpression of DN-JAK2 together with hIL-5R and c into COS7 cells also completely inhibited hIL-5-induced JAK1 activation. In contrast, JAK2 activation was conserved regardless of DN-JAK1 introduction into COS7 cells (Fig 5A). The hIL-5-mediated tyrosine phosphorylation of c was suppressed following transfection with DN-JAK2 (Fig 5B). These results indicate that JAK2 activation alone is sufficient to induce tyrosine phosphorylation of c in response to hIL-5 and JAK1 activation is not essential. View larger version (25K): [in this window] [in a new window]   Fig 5. Effects of DN-JAK1 and in DN-JAK2 on IL-5 signal. (A) hIL-5R and c cDNA were transfected into COS7 cells together with either a vector control, a kinase-negative form of JAK1, or a kinase-negative form of JAK2. After incubation for 36 hours, cells were harvested and lysed after IL-5 stimulation. Immunoprecipitation was performed with anti-JAK1 or -JAK2 Ab. After separation on SDS-PAGE, the transferred membranes were immunoblotted with antiphosphotyrosine MoAb and reprobed with the relevant Ab. (B) Immunoprecipitation with anti-c MoAb was also performed. After separation on SDS-PAGE, the proteins were probed with antiphosphotyrosine MoAb and reprobed with anti-c polyclonal Ab.     DISCUSSION Abstract Introduction Methods Results Discussion References In this study, we report the following three major findings. First, we demonstrated that each component of the hIL-5R complex, hIL-5R and c, exists independently in the absence of IL-5, and c can be recruited to hIL-5R upon hIL-5 stimulation. Second, in unstimulated conditions, JAK2 and JAK1 are constitutively associated with hIL-5R and c, respectively. The cytoplasmic proline-rich region of hIL-5R is necessary for JAK2 binding. Third, hIL-5 stimulation induces activation of both JAK1 and JAK2, resulting in tyrosine phosphorylation of cellular proteins including c and STAT5. Tyrosine phosphorylation of JAK1 depends on the activation of JAK2. These results were obtained by successful generation of MoAbs against hIL-5R and by detailed study of the C-terminal truncated cytoplasmic domain of hIL-5R using GST fusion proteins. The hIL-5R complex is composed of two subunits, the ligand-specific hIL-5R and c. Although it has been speculated that a heterodimerization of IL-5R subunits induces the IL-5 signal, the nature of hIL-5R and c heterodimerization has yet to be shown biochemically. It has been suggested that a functional hIL-5R complex is not preformed tightly, based on the finding that GM-CSF and IL-3 can cross-compete with IL-5 for binding and biologic activity.30 We were able to demonstrate that hIL-5R and c were not associated in the absence of IL-5, and that the c would associate with hIL-5R only after IL-5 stimulation (Fig 1A), consistent with a recent report on IL-3R.11,12 The monomeric hIL-5, mono5,26 which is biologically active like the intact dimeric hIL-5, also triggered the interaction of c with hIL-5R, similar to native dimeric hIL-5 (Fig 1A). hIL-3-induced heterodimerization of an IL-3R and c has been shown to occur by covalent and noncovalent means. It has also been shown that receptor activation such as the tyrosine phosphorylation of c is associated with the disulfide-linked receptor complex that contains both hIL-3R and c.11,12 We examined the nature of hIL-5-induced heterodimerization of IL-5R and c under nonreducing conditions and found, in addition to a tyrosine-phosphorylated monomeric c, a 220-kD molecule that was tyrosine-phosphorylated in the presence of hIL-5 to coimmunoprecipitate with anti-hIL-5R MoAb (data not shown). However, we were unable to identify the band as a hIL-5R and c heterodimer with our immunoblot analysis. Most of the tyrosine-phosphorylated IL-5R complexes were at least c-bound to hIL-5R noncovalently (data not shown). Moreover, in contrast to the human GM-CSFR where a preformed homodimeric c forms the functional complex with GM-CSFR in GM-CSF signaling,10 we have no evidence that a functional hIL-5R complex uses a preformed homodimeric c. The basis for these differences is not yet known. Further analysis such as crystallization of the IL-5/IL-5R/c, IL-3/IL-3R/c, and GM-CSF/GM-CSFR/c complexes will aid in understanding the stoichiometry of these receptor complexes. The physical interaction between many cytokine receptors and JAKs have been reported in the literature.31,32 In this study, we were able to demonstrate that JAK2 and JAK1 associate with the hIL-5R and c, respectively. Previously, we have been able to detect activation of JAK1, but not JAK2, upon mIL-5 stimulation of FDC-P1 transfectants expressing both the intact c and the chimera, which is composed of the extracellular and membrane domains of mIL-5R and the cytoplasmic domain of c.24 We inferred from this observation that homodimerization of the c cytoplasmic domain by the chimera receptor activates JAK1 but not JAK2, resulting in transduction of the mIL-5 signal. The present finding is consistent with this notion. Furthermore, it was recently reported that JAK2 physically associates with c only after ligand stimulation in a c-sharing receptor complex in mammalian cells.33-35 Although it was not determined in those reports whether a ligand-specific  subunit is coimmunoprecipitated with the c, it is possible to speculate that the JAK2 coimmunoprecipitated along with c may be derived from JAK2 bound to the ligand-specific  subunit. However, these observations are inconsistent with a previous report that JAK2 constitutively associated with the c subunit but not the GM-CSFR subunit when they were expressed in insect cells using the baculovirus expression vector.36 We do not have a good explanation as to why we obtained results different from theirs. The very high concentrations achieved in the insect cells may be involved in changing the affinity of JAK2. What is demonstrated in this study is that JAK2 associates with hIL-5R in hIL-5-dependent cell lines (in vivo), and JAK2 associates with the fusion protein containing the cytoplasmic region of hIL-5R (in vitro). Furthermore, the region of hIL-5R necessary for JAK2 binding was localized to the domain of amino acid residues 346 to 387 of the hIL-5R cytoplasmic region. It was also revealed that the region containing particularly the proline-rich residues is indispensable for JAK2 association. We diligently performed point mutation analyses to determine which proline residue(s) would be important for JAK2 binding. Unfortunately, we did not obtain clear-cut and reproducible results, probably because of technical problems. We believe that the point mutation analysis for an in vitro binding assay using fusion protein may be accomplished by a technique with improved protein chemistry. This would be the next issue to be solved. Finally, we examined the role of JAKs in hIL-5 signaling using the dominant-negative variants DN-JAK1 and DN-JAK2. Interestingly, JAK1 activation was not observed in the absence of JAK2 activation, whereas JAK2 activation was induced upon hIL-5 stimulation irrespective of JAK1 activation (Fig 5A). As in the case of GM-CSFR,25 DN-JAK2 inhibited hIL-5-induced tyrosine phosphorylation of c. On the other hand, tyrosine phosphorylation of c could be achieved in the absence of JAK1. Thus, JAK1 activation seems dispensable for hIL-5R activation, similar to a recent report on hIL-2R-mediated signaling37,38 whereby JAK1 but not JAK3 was dispensable for hIL-2R function. It should be noted that the tyrosine phosphorylation of JAK2 was reduced somewhat by induction of DN-JAK1, which was obtained by three independent experiments. It has also been observed that overexpression of wild-type JAK1 together with c in COS7 cells induces tyrosine phosphorylation of cotransfected c, which was also induced by overexpression of wild-type JAK2 (data not shown). These results suggest that JAK1 enhances hIL-5-induced signaling events via further activation of JAK2 and tyrosine phosphorylation of c. It has been proposed that the stoichiometry of the hIL-5R, c, and IL-5 complex is 1:1:1.39-41 Based on our present observations, we speculate that JAK2 associated with hIL-5R interacts with JAK1 of the c subunit by heterodimerization and transduces the signal of hIL-5. However, JAK2 activation is observed in the absence of JAK1 activation. These results suggest the possible existence of a non-JAK1 necessary for JAK2 activation. Lyn has been shown to be constitutively associated with c and activated by hIL-5.42,43 Therefore, it will be interesting to examine the possible involvement of Lyn in the activation of JAKs. We also cannot rule out the possibility that JAK2 binds to c in a fashion undetected by our experiments, which may result in the cross-phosphorylation of JAK2 itself. Since a recent report has proposed that a c-sharing receptor complex may be composed of a ligand: subunit:c subunit stoichiometry of 2:2:2 configuration,12 it is also possible that the interaction of JAK2 bound to IL-5R is activated by cross-phosphorylation. In conclusion, hIL-5R provides not only a ligand-specific binding site but also site(s) for a signaling kinase molecule such as JAK2. Furthermore, JAK2 bound to hIL-5R regulates the initiation of IL-5 signaling. Furthermore, JAK1 bound to c, although dispensable, is involved in IL-5R-mediated signal transduction. These observations provide new clues for understanding the molecular mechanisms of IL-5 signal transduction in human eosinophils.     FOOTNOTES    Submitted April 22, 1997; accepted November 10, 1997.    Supported in part by a Special Grant for Advanced Research on Immunology and a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, and Culture of Japan; a grant from the Japan Research Foundation of Clinical Pharmacology; and research funds from Bayer Pharmaceutical Co and Ono Pharmaceutical Co.    Address reprint requests to Kiyoshi Takatsu, PhD, Department of Immunology, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108, Japan.    The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" is accordance with 18 U.S.C. section 1734 solely to indicate this fact.     ACKNOWLEDGMENT We thank Drs M. Tomonaga and R. Dickason for providing YY-1 cells and mono5, respectively. We also acknowledge Drs Y. Kikuchi, K. Ishizaka, R. Dickason, and E. Barsoumian for suggestions throughout the study and a critical review of the manuscript.     REFERENCES Abstract Introduction Methods Results Discussion References 1. Takatsu K: Interleukin-5. Curr Opin Immunol 4:299, 1992[Medline] [Order article via Infotrieve] 2. Takatsu K, Takaki S, Hitoshi Y: Interleukin-5 and its receptor system: Implications in the immune system and inflammation. Adv Immunol 57:145, 1994[Medline] [Order article via Infotrieve] 3. Sanderson CJ: Interleukin-5, eosinophils, and disease. Blood 79:3101, 1992[Free Full Text] 4. Miyajima A: Molecular structure of the IL-3, GM-CSF and IL-5 receptors. Int J Cell Cloning 10:126, 1992[Medline] [Order article via Infotrieve] 5. Murata Y, Takaki S, Migita M, Kikuchi Y, Tominaga A, Takatsu K: Molecular cloning and expression of the human interleukin 5 receptor. J Exp Med 175:341, 1992[Abstract/Free Full Text] 6. Tavernier J, Devos R, Cornelis S, Tuypens T, Van der Heyden J, Fiers W, Plaetinck G: A human high affinity interleukin-5 receptor (IL5) is composed of an IL5-specific  chain and a  chain shared with the receptor for GM-CSF. Cell 66:1175, 1991[Medline] [Order article via Infotrieve] 7. Takaki S, Murata Y, Kitamura T, Miyajima A, Tominaga A, Takatsu K: Reconstitution of the functional receptors for murine and human interleukin 5. J Exp Med 177:1523, 1993[Abstract/Free Full Text] 8. Kitamura T, Sato N, Arai K, Miyajima A: Expression cloning of the human IL-3 receptor cDNA reveals a shared  subunit for the human IL-3 and GM-CSF receptors. Cell 66:1165, 1991[Medline] [Order article via Infotrieve] 9. Hayashida K, Kitamura K, Gorman DM, Arai K, Yokota T, Miyajima A: Molecular cloning of a second subunit of the receptor for human granulocyte-macrophage colony-stimulating factor (GM-CSF): Reconstitution of a high-affinity GM-CSF receptor. Proc Natl Acad Sci USA 87:9655, 1990[Abstract/Free Full Text] 10. Muto A, Watanabe S, Miyajima A, Yokota T, Arai K: The  subunit of human granulocyte-macrophage colony-stimulating factor receptor forms a homodimer and is activated via association with the  subunit. J Exp Med 183:1911, 1996[Abstract/Free Full Text] 11. Stomski FC, Sun Q, Bagley CJ, Woodcock J, Goodall G, Andrew RK, Berndt MC, Lopez AF: Human interleukin-3 (IL-3) induces disulfide-liked IL-3 receptor - and -chain heterodimerization, which is required for receptor activation but not high-affinity binding. Mol Cell Biol 16:3035, 1996[Abstract] 12. Bagley CJ, Woodcock JM, Stomski FC, Lopez AF: The structural and functional basis of cytokine receptor activation: Lessons from the common  subunit of the granulocyte-macrophage colony-stimulating factor, interleukin-3 (IL-3), and IL-5 receptors. Blood 89:1471, 1997[Free Full Text] 13. Takaki S, Kanazawa H, Shiiba M, Takatsu K: A critical cytoplasmic domain of the interleukin-5 (IL-5) receptor  chain and its function in IL-5-mediated growth signal transduction. Mol Cell Biol 14:7404, 1994[Abstract/Free Full Text] 14. Sato S, Katagiri T, Takaki S, Kikuchi Y, Hitoshi Y, Yonehara S, Tsukada S, Kitamura D, Watanabe T, Witte O, Takatsu K: IL-5 receptor-mediated tyrosine phosphorylation of SH2/SH3-containing proteins and activation of Bruton's tyrosine and Janus 2 kinases. J Exp Med 180:2101, 1994[Abstract/Free Full Text] 15. Silvennoinen O, Witthuhn BA, Quelle FW, Cleveland JL, Yi T, Ihle JN: Structure of the murine Jak2 protein-tyrosine kinase and its role in interleukin 3 signal transduction. Proc Natl Acad Sci USA 90:8429, 1993[Abstract/Free Full Text] 16. Firmbach-Kraft I, Byers M, Shows T, Dalla-Favera R, Krolewski JJ: Tyk2, prototype of a novel class of non-receptor tyrosine kinase genes. Oncogene 5:1329, 1990[Medline] [Order article via Infotrieve] 17. Witthuhn BA, Quelle FW, Silvennoinen O, Yi T, Tang B, Miura O, Ihle JN: JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 74:227, 1993[Medline] [Order article via Infotrieve] 18. Kishimoto T, Taga T, Akira S: Cytokine signal transduction. Cell 76:253, 1994[Medline] [Order article via Infotrieve] 19. Taniguchi T: Cytokine signaling through nonreceptor protein tyrosine kinases. Science 268:251, 1995[Abstract/Free Full Text] 20. van der Bruggen T, Caldenhoven E, Kanters D, Coffer P, Raaijmakers JAM, Lammers JWJ, Koenderman L: Interleukin-5 signaling in human eosinophils involves JAK2 tyrosine kinase and Stat1. Blood 85:1442, 1995[Abstract/Free Full Text] 21. Pazdrak K, Justement L, Alam R: Mechanism of inhibition of eosinophils activation by transforming growth factor-. Inhibition of Lyn, MAP, Jak2 kinases and STAT1 nuclear factor. J Immunol 155:4454, 1995[Abstract] 22. (suppl) Ogata N, Kikuchi Y, Kouro T, Takatsu K: The activation of the JAK2/STAT5 pathway is commonly involved in signaling through the human interleukin-5 receptor. Int Arch Allergy Immunol 114:24, 1997 23. Bates ME, Bertcs PJ, Busse WW: IL-5 activates a 45-kilodalton mitogen-activated protein (MAP) kinase and Jak-2 tyrosine kinase in human eosinophils. J Immunol 156:711, 1996[Abstract] 24. Kouro T, Kikuchi Y, Kanazawa H, Hirokawa K, Harada N, Shiiba M, Wakao H, Takaki S, Takatsu K: Critical proline residues of the cytoplasmic domain of the IL-5 receptor  chain and its function in IL-5-mediated activation of JAK kinases and STAT5. Int Immunol 8:237, 1996[Abstract/Free Full Text] 25. Watanabe S, Itoh T, Arai K: JAK2 is essential for activation of c-fos and c-myc promoters and cell proliferation through the human granulocyte-macrophage colony-stimulating factor receptors in BA/F3 cells. J Biol Chem 271:12681, 1996[Abstract/Free Full Text] 26. Dickason RR, Huston DP: Creation of a biologically active interleukin-5 monomer. Nature 379:652, 1996[Medline] [Order article via Infotrieve] 27. (abstr) Koike M, Iida A, Shoji E, Mikuni O, Furuya A, Anazawa H, Takaki S, Takatsu K, Hanai N: Monoclonal antibodies recognizing human interleukin 5 receptor alpha chain. Tissue Antigens 48:390, 1996 28. Kitamura T, Tange T, Terasawa T, Chiba S, Kuwaki T, Pia YF, Miyazono K, Urabe A, Takaku F: Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J Cell Physiol 140:323, 1989[Medline] [Order article via Infotrieve] 29. van den Hoff MJB, Moorman AFM, Lamers WH: Electroporation in `intracellular' buffer increases cell survival. Nucleic Acids Res 20:2902, 1992[Free Full Text] 30. Lopez AF, Vadas MA, Woodcock JM, Milton SE, Lewis A, Elliott MJ, Gillis D, Ireland R, Olwell E, Park LS: Interleukin-5, interleukin-3, and granulocyte-macrophage colony-stimulating factor cross-compete for binding to cell surface receptors on human eosinophils. J Biol Chem 266:24741, 1991[Abstract/Free Full Text] 31. Argetsinger LS, Campbell GS, Yang X, Witthuhn BA, Silvennoinen O, Ihle JN, Carter-Su C: Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell 74:237, 1993[Medline] [Order article via Infotrieve] 32. Stahl N, Boulton TG, Farruggella T, Ip NY, Davis S, Witthuhn BA, Quelle FW, Silvennoinen O, Barbieri G, Pellegrini S, Ihle JN, Yancopoulos GD: Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6  receptor components. Science 263:92, 1994[Abstract/Free Full Text] 33. Chin H, Wakao H, Miyajima A, Kamiyama R, Miyasaka N, Miura O: Erythropoietin induces tyrosine phosphorylation of the interleukin-3 receptor  subunit (IL-3) and recruitment of Stat5 to possible Stat5-docking sites in IL-3. Blood 89:4327, 1997[Abstract/Free Full Text] 34. Cattaneo E, De Fraja C, Conti L, Renach B, Bolos L, Govoni S, Liboi E: Activation of JAK/STAT pathway leads to proliferation of ST14A central nervous system progenitor cells. J Biol Chem 271:23374, 1996[Abstract/Free Full Text] 35. Brizzi MF, Aronoca MG, Rosso A, Bagnara GP, Yarden Y, Pegoraro L: Granulocyte-macrophage colony-stimulating factor stimulates JAK2 signaling pathway and rapidly activates p93fes, STAT1 p91, and STAT3 p92 in polymorphonuclear leukocytes. J Biol Chem 27:3562, 1996 36. Quelle FW, Sato N, Witthuhn BA, Inhorn RC, Eder M, Miyajima A, Griffin JD, Ihle JN: JAK2 associates with the c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region. Mol Cell Biol 14:4335, 1994[Abstract/Free Full Text] 37. Higuchi M, Asao H, Tanaka N, Oda K, Takeshita T, Nakamura M, van Snick J, Sugamura K: Dispensability of Jak1 tyrosine kinase for interleukin-2-induced cell growth signaling in a human T cell line. Eur J Immunol 26:1322, 1996[Medline] [Order article via Infotrieve] 38. Oakes SA, Candotti F, Johnston JA, Chen YQ, Ryan JJ, Tayor N, Liu X, Hennighausen L, Notarangelo LD, Paul WE, Blaese RM, O'Shea JJ: Signaling via IL-2 and IL-4 in JAK3-deficient severe combined immunodeficiency lymphocytes: JAK3-dependent and independent pathways. Immunity 5:605, 1996[Medline] [Order article via Infotrieve] 39. Johanson K, Applebaum E, Doyle M, Hensley P, Zhao B, Abdel-Meguid SS, Young P, Cook R, Carr S, Matico R, Cusimano D, Dul E, Angelichio M, Brooks I, Winborne E, McDonnell P, Morton T, Bennett D, Sokoloski T, McNulty D, Rosenberg M, Chaiken I: Binding interactions of human interleukin 5 with its receptor  subunit. J Biol Chem 270:9459, 1995[Abstract/Free Full Text] 40. Devos R, Guisez Y, Cornelius S, Verhee A, Van der Heyden J, Manneberg M, Lahm HW, Fiers W, Tavernier J, Plaetinck G: Recombinant soluble human interleukin-5 (hIL-5) receptor molecules. Cross-linking and stoichiometry of binding to IL-5. J Biol Chem 268:6581, 1993[Abstract/Free Full Text] 41. Li J, Cook R, Chaiken I: Mutants of single chain interleukin 5 show asymmetric recruitment of receptor  and c subunits. J Biol Chem 271:31729, 1996[Abstract/Free Full Text] 42. Pazdrak K, Schreiber D, Forsythe P, Justement L, Alam R: The intercellular signal transduction mechanism of interleukin 5 in eosinophils: The involvement of lyn tyrosine kinase and the Ras-Raf-1-MEK microtubule-associated protein kinase pathway. J Exp Med 181:1827, 1995[Abstract/Free Full Text] 43. Yousefi S, Hoessli DC, Blaser K, Mills GB, Simon HU: Requirement of Lyn and Syk tyrosine kinases for the prevention of apoptosis by cytokines in human eosinophils. J Exp Med 183:1407, 1996[Abstract/Free Full Text] © 1998 by The American Society of Hematology.   0006-4971/98/91-0035$3.00/0 CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this? This article has been cited by other articles: T. Kouro and K. Takatsu IL-5- and eosinophil-mediated inflammation: from discovery to therapy Int. Immunol., December 1, 2009; 21(12): 1303 - 1309. [Abstract] [Full Text] [PDF] J. M. Beekman, L. P. Verhagen, N. Geijsen, and P. J. Coffer Regulation of myelopoiesis through syntenin-mediated modulation of IL-5 receptor output Blood, October 29, 2009; 114(18): 3917 - 3927. [Abstract] [Full Text] [PDF] Y. Mori, H. Iwasaki, K. Kohno, G. Yoshimoto, Y. Kikushige, A. Okeda, N. Uike, H. Niiro, K. Takenaka, K. Nagafuji, et al. Identification of the human eosinophil lineage-committed progenitor: revision of phenotypic definition of the human common myeloid progenitor J. Exp. Med., January 16, 2009; 206(1): 183 - 193. [Abstract] [Full Text] [PDF] J. T. Lei and M. Martinez-Moczygemba Separate endocytic pathways regulate IL-5 receptor internalization and signaling J. Leukoc. Biol., August 1, 2008; 84(2): 499 - 509. [Abstract] [Full Text] [PDF] M. Zaks-Zilberman, A. E. Harrington, T. Ishino, and I. M. Chaiken Interleukin-5 Receptor Subunit Oligomerization and Rearrangement Revealed by Fluorescence Resonance Energy Transfer Imaging J. Biol. Chem., May 9, 2008; 283(19): 13398 - 13406. [Abstract] [Full Text] [PDF] M. Martinez-Moczygemba, D. P. Huston, and J. T. Lei JAK kinases control IL-5 receptor ubiquitination, degradation, and internalization J. Leukoc. Biol., April 1, 2007; 81(4): 1137 - 1148. [Abstract] [Full Text] [PDF] B.-g. Moon, S. Takaki, K. Miyake, and K. Takatsu The Role of IL-5 for Mature B-1 Cells in Homeostatic Proliferation, Cell Survival, and Ig Production J. Immunol., May 15, 2004; 172(10): 6020 - 6029. [Abstract] [Full Text] [PDF] M. Buitenhuis, B. Baltus, J.-W. J. Lammers, P. J. Coffer, and L. Koenderman Signal transducer and activator of transcription 5a (STAT5a) is required for eosinophil differentiation of human cord blood-derived CD34+ cells Blood, January 1, 2003; 101(1): 134 - 142. [Abstract] [Full Text] [PDF] T. J. Blake, B. J. Jenkins, R. J. D'Andrea, and T. J. Gonda Functional cross-talk between cytokine receptors revealed by activating mutations in the extracellular domain of the {beta}-subunit of the GM-CSF receptor J. Leukoc. Biol., December 1, 2002; 72(6): 1246 - 1255. [Abstract] [Full Text] [PDF] S. Stafford, C. Lowell, S. Sur, and R. Alam Lyn Tyrosine Kinase Is Important for IL-5-Stimulated Eosinophil Differentiation J. Immunol., February 15, 2002; 168(4): 1978 - 1983. [Abstract] [Full Text] [PDF] K. Horikawa, H. Kaku, H. Nakajima, H. W. Davey, L. Henninghausen, I. Iwamoto, T. Yasue, A. Kariyone, and K. Takatsu Essential Role of Stat5 for IL-5-Dependent IgH Switch Recombination in Mouse B Cells J. Immunol., November 1, 2001; 167(9): 5018 - 5026. [Abstract] [Full Text] [PDF] H.-M. Huang, C.-J. Huang, and J. J.-Y. Yen Mcl-1 is a common target of stem cell factor and interleukin-5 for apoptosis prevention activity via MEK/MAPK and PI-3K/Akt pathways Blood, September 1, 2000; 96(5): 1764 - 1771. [Abstract] [Full Text] [PDF] M. E. Bates, V. L. Green, and P. J. Bertics ERK1 and ERK2 Activation by Chemotactic Factors in Human Eosinophils Is Interleukin 5-dependent and Contributes to Leukotriene C4 Biosynthesis J. Biol. Chem., April 6, 2000; 275(15): 10968 - 10975. [Abstract] [Full Text] [PDF] S.-F. Lee, H.-M. Huang, J.-R. Chao, S. Lin, H.-F. Yang-Yen, and J. J.-Y. Yen Cytokine Receptor Common beta Chain as a Potential Activator of Cytokine Withdrawal-Induced Apoptosis Mol. Cell. Biol., November 1, 1999; 19(11): 7399 - 7409. [Abstract] [Full Text] [PDF] P. C. Orban, M. K. Levings, and J. W. Schrader Heterodimerization of the alpha and beta Chains of the Interleukin-3 (IL-3) Receptor Is Necessary and Sufficient for IL-3-Induced Mitogenesis Blood, September 1, 1999; 94(5): 1614 - 1622. [Abstract] [Full Text] [PDF] P. L. Orchansky, R. Kwan, F. Lee, and J. W. Schrader Characterization of the Cytoplasmic Domain of Interleukin-13 Receptor-alpha J. Biol. Chem., July 23, 1999; 274(30): 20818 - 20825. [Abstract] [Full Text] [PDF] T. Adachi, K. Pazdrak, S. Stafford, and R. Alam The Mapping of the Lyn Kinase Binding Site of the Common {beta} Subunit of IL-3/Granulocyte-Macrophage Colony- Stimulating Factor/IL-5 Receptor J. Immunol., February 1, 1999; 162(3): 1496 - 1501. [Abstract] [Full Text] [PDF] T. Adachi and R. Alam The mechanism of IL-5 signal transduction Am J Physiol Cell Physiol, September 1, 1998; 275(3): C623 - C633. [Abstract] [Full Text] [PDF] J. Du, Y. M. Alsayed, F. Xin, S. J. Ackerman, and L. C. Platanias Engagement of the CrkL Adapter in Interleukin-5 Signaling in Eosinophils J. Biol. Chem., October 13, 2000; 275(42): 33167 - 33175. [Abstract] [Full Text] [PDF] This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Ogata, N. Articles by Takatsu, K. Search for Related Content PubMed PubMed Citation Articles by Ogata, N. Articles by Takatsu, K. Related Collections Hematopoiesis and Stem Cells Social Bookmarking                   What's this?

	Copyright © 1998 by American Society of Hematology         Online ISSN: 1528-0020